Skip to main content

A Strategic Analysis of Vaccine Access for Developing Countries

Date created
Vaccination has been one of the major successes in global health, providing a costeffective method of reducing morbidity and mortality. However, middle- and low-income countries are often unable to access newer vaccines in a timely manner. This analysis outlines market-influenced solutions that address the inequity. First, the current state of the vaccine industry and the roles of manufacturers are examined, and then the impact of innovation on the industry is assessed. High-, middle- and low-income country markets are compared. Finally, an assessment is made of the models that increase vaccine access. The industry, innovation impact, market and access model analyses lead to a proposal of a complementary strategic plan for improved vaccine access for developing countries. This analysis defines the key success factors for future vaccine development and manufacturing that will equilibrate vaccine use across the globe.
MOT MBA Project-Simon Fraser University
Copyright statement
Copyright is held by the author(s).
You are free to copy, distribute and transmit this work under the following conditions: You must give attribution to the work (but not in any way that suggests that the author endorses you or your use of the work); You may not use this work for commercial purposes.
Scholarly level
Peer reviewed?

Views & downloads - as of June 2023

Views: 0
Downloads: 0